KAZIA THERAPEUTICS-SPON ADR (KZIA) Stock Income Statement
NASDAQ:KZIA • US48669G3039
Current stock price
11.1 USD
+0.18 (+1.65%)
Last:
| TTM (2025-12-31) | 2025 (2025-6-30) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 246.20K | 114.00K | 2.32M | 22.60K | 2.10K | |||
| Minority Interest Expense | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 19.94M | 18.32M | 29.51M | 24.15M | 25.38M | |||
| Research and Development | 8.04M | 6.39M | 15.51M | 15.56M | 20.17M | |||
| Selling, General, and Administrative Expenses | 12.17M | 8.72M | 13.56M | 8.58M | 5.23M | |||
| Operating Income | -19.69M | -18.20M | -27.19M | -24.12M | -25.38M | |||
| Interest Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Other Income/Expense | 1.86M | 1.58M | 0.00 | 600.00 | 0.00 | |||
| Non Recurring Items | -6.58M | -5.83M | 144.00K | 3.39M | 0.00 | |||
| Income Before Taxes | -24.41M | -22.45M | -27.05M | -20.74M | -25.38M | |||
| Income Tax | -1.61M | -1.75M | -271.00K | -271.10K | -368.10K | |||
| Net Income | -22.80M | -20.70M | -26.78M | -20.47M | -25.01M | |||
| EBITDA | N/A | N/A | N/A | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.49 | -5.16 | -69.33 | -758.14 | -1.29K | |||
| Non GAAP EPS | 0.61 | N/A | N/A | N/A | N/A | |||
| Statistics | ||||||||
| Profit Margin | -9261.05% | -18159.65% | -1154.22% | -90553.98% | -1191147.62% | |||
| Operating Profit Margin | -7998.70% | -15965.79% | -1172.11% | -106745.58% | -1208671.43% | |||
All data in AUD